Exhibit 3.
Medication use, spending, and distribution of spending by source for psychotropic medications and all medications in 2005 and 2006, Civilian Non-Institutionalized Medicare Population
| % With | Total | Percent Distribution of Spending by Source |
||||||
|---|---|---|---|---|---|---|---|---|
| Use | Spending | OOP | Medicare | Medicaid | Private | Other | ||
| 2005 | ||||||||
| Antidepressants (all) | 16.0 | 3.8b | 41 | 8 | 18 | 23 | 10 | |
| SSRI, SSNRI other newer | 13.7 | 3.6b | 41 | 7 | 18 | 23 | 10 | |
| Antipsychotics (all) | 3.3 | 2.1b | 25 | 4 | 64 | 4 | 3 | |
| atypicals | 2.7 | 2.0b | 24 | 4 | 66 | 3 | 3 | |
| Anticonvulsants | 7.0 | 2.1b | 29 | 4 | 35 | 22 | 9 | |
| ALL DRUGS | 91.0 | 88.5b | 43 | 7 | 16 | 23 | 11 | |
| 2006 | ||||||||
| Antidepressants (all) | 18.1* | 4.1b | 32* | 52* | 1* | 10* | 5* | |
| SSRI, SSNRI, other newer | 16.1* | 3.8b | 32* | 51* | 1* | 11* | 5* | |
| Antipsychotics (all) | 3.6 | 1.9b | 22 | 61* | 6* | 4 | 7 | |
| atypicals | 2.9 | 1.8b | 23 | 61* | 5* | 4 | 6 | |
| Anticonvulsants | 7.2 | 1.9b | 31 | 48* | 2* | 12 | 7 | |
| ALL DRUGS | 91.2 | 96.3b | 31* | 45* | 1* | 14 | 8* | |
SOURCE: 2005–2006 MEPS
*
Difference between 2005 and 2006 significant at P=0.05 level. Exhibit does not include in “clawback” payments made by the states to the federal government.